Submit Deal

ONCOINVENT

Summary

Oncoinvent is a Norwegian, clinical-stage radiopharmaceutical company that develops direct alpha therapy for solid cancers.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 12 M

Avg. Deal Size£ 12 M

Market Context

Senior Management

Sort

dnb carnegie investment bank

HQ - Stockholm

financial advisors (1)

1 Shared Deal

1 Opposite

£ 12 M

Total Value

thommessen

HQ - Oslo

legal advisors (1)

1 Shared Deal

1 Opposite

£ 12 M

Total Value

schjodt

HQ - Oslo, Norway

legal advisors (1)

1 Shared Deal

1 For

£ 12 M

Total Value

abg sundal collier

HQ - Oslo

financial advisors (1)

1 Shared Deal

1 For

£ 12 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy